Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-13-036150
Filing Date
2013-06-21
Accepted
2013-06-21 17:20:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT - RULE 424(B)(5) v348253_424b5.htm 424B5 128818
2 GRAPHIC logo1.jpg GRAPHIC 10267
3 GRAPHIC logo2.jpg GRAPHIC 4773
  Complete submission text file 0001144204-13-036150.txt   151064
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

EIN.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-189015 | Film No.: 13928011
SIC: 2834 Pharmaceutical Preparations